Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.24 USD | -0.88% | +3.35% | +88.84% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.84% | 1.46B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- TARS Stock
- News Tarsus Pharmaceuticals, Inc.
- Tarsus Pharmaceuticals Says Phase 2a Trial of TP-03 in Meibomian Gland Disease Yields Positive Results